US Broker Ratings

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 65% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take a closer look at CG Oncology, Inc. (CGON), a prominent player in the healthcare industry focused on groundbreaking bladder..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating the Healthcare Giant’s 8.16% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the U.S. healthcare sector, operates within the medical care facilities industry. With a market capitalization of $2.54 billion, the company..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape Amidst High Valuation

Investors with a keen eye on the biotechnology sector might find Galapagos NV (NASDAQ: GLPG) an intriguing study in contrasts. With a market capitalization of $2.11 billion, this Belgian company..

Phreesia, Inc. (PHR)

⚠️ No article content returned.

..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 63% Upside Potential in the Innovative Bioelectric Medicine Space

As investors seek opportunities in the ever-evolving healthcare sector, Pulse Biosciences, Inc (NASDAQ: PLSE) emerges as a captivating prospect, especially with a potential upside of 63.08%. Specializing in the burgeoning..

Astrana Health Inc. (ASTH) Stock Analysis: Potential 82.95% Upside as Revenue Nears 100% Growth

Astrana Health Inc. (NASDAQ: ASTH) is capturing the attention of investors with its remarkable revenue growth and substantial upside potential. Founded in 1994, the Alhambra, California-based company, formerly known as..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Healthcare Innovator with 14% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a pioneering force in the healthcare sector, is capturing investor attention with its strong potential for growth. Specializing in medical devices, this Carlsbad, California-based company..

MannKind Corporation (MNKD) Stock Analysis: Potential Upside of 66.77% Captivates Investors

MannKind Corporation (NASDAQ: MNKD), a pioneering biopharmaceutical company, is becoming a focal point for investors seeking promising opportunities in the healthcare sector. With its dedication to developing innovative therapies for..

Protagonist Therapeutics, Inc. (PTGX) Investor Outlook: Strong Buy Ratings Highlight Promising Growth in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical company focused on innovative peptide therapeutics, has captured the attention of investors with its promising pipeline and strong analyst endorsements. Specializing in treatments..

Ocular Therapeutix, Inc. (OCUL): Investor Outlook Reveals 47% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) has caught the eye of investors with its promising potential upside of 47.42%, according to recent analyst ratings. As a biopharmaceutical company focused on innovative..

AdaptHealth Corp. (AHCO): Investor Outlook Reveals 41% Potential Upside in Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the medical devices industry, presents a compelling investment opportunity with a projected upside of over 41%. Specializing in home medical equipment and..

Celldex Therapeutics (CLDX) Investor Outlook: A Biotech Stock with a Promising 78% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands at the forefront of the biotechnology sector, capturing investor attention with its cutting-edge research and promising drug candidates. As a biopharmaceutical company, Celldex is..

Mesoblast Limited (MESO) Stock Analysis: Eye-Catching Potential Upside for Biotechnology Investors

Mesoblast Limited (NASDAQ: MESO), an innovative leader in regenerative medicine, is capturing investor attention with a striking potential upside of 93.26%. Specializing in cutting-edge biotechnology, Mesoblast harnesses the power of..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 169.57% Potential Upside in Healthcare Innovation

Opko Health, Inc. (NASDAQ: OPK) operates at the intersection of diagnostics and pharmaceuticals, delivering a diverse range of healthcare solutions across the United States and internationally. With a market capitalization..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: High Potential Upside with 12 Buy Ratings

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning player in the biotechnology sector, has quickly attracted investor attention due to its strategic focus on developing novel biologics targeting a range of..

ANI Pharmaceuticals (ANIP) Stock Analysis: Evaluating a Potential 33.73% Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, is capturing investor attention with its promising potential upside of 33.73%. Specializing in both branded and generic pharmaceutical..

Premier, Inc. (PINC) Stock Analysis: A Steady Dividend Payout Amidst Revenue Challenges

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, primarily operates within the health information services industry. The company, headquartered in Charlotte, North Carolina, has established itself as..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the Growth Potential Amidst a Challenging Market Landscape

As the healthcare sector continues to evolve, 10x Genomics, Inc. (NASDAQ: TXG) stands out with its cutting-edge life science technology aimed at revolutionizing the analysis of biological systems. Despite a..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 19% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) operates at the intersection of innovation and healthcare, providing a wide array of medical devices aimed at improving surgical outcomes and patient care. With..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 62% Upside Potential

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) has emerged as a compelling player in the biotechnology sector, particularly for investors seeking exposure to innovative treatments for muscle disorders. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds